Schedule 13D

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Schedule 13D

 

Under the Securities Exchange Act of 1934

(Amendment No.    )

 

 

 

Integramed America, Inc.

(Name of Issuer)

 

 

Common Stock

(Title of Class of Securities)

 

 

45810N302

(CUSIP Number)

 

 

Jeffery R. Schaffart

Koley Jessen P.C., L.L.O.

One Pacific Place

1125 South 103 Street, Suite 800

Omaha, NE 68124

Phone: (402) 390-9500

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

 

December 22, 2008

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box  ¨.

 

Page 1 of 17


CUSIP No. 45810N302

 

  1  

NAME OF REPORTING PERSON.

 

            Blue TSV I, LTD

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

SOURCE OF FUNDS (See Instructions)

 

            WC

   
  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ¨
  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Cayman Islands

   

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  7    SOLE VOTING POWER

 

                349,304

 

  8    SHARED VOTING POWER

 

                0

 

  9    SOLE DISPOSITIVE POWER

 

                349,304

 

10    SHARED DISPOSITIVE POWER

 

                0

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            735,734

   
12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ¨
13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            8.5%

   
14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

            CO

   

 

Page 2 of 17


CUSIP No. 45810N302

 

  1  

NAME OF REPORTING PERSON.

 

            BlueLine Capital Partners, L.P.

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

SOURCE OF FUNDS (See Instructions)

 

            WC

   
  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ¨
  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  7    SOLE VOTING POWER

 

                0

 

  8    SHARED VOTING POWER

 

                92,488

 

  9    SOLE DISPOSITIVE POWER

 

                0

 

10    SHARED DISPOSITIVE POWER

 

                92,488

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            735,734

   
12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ¨
13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            8.5%

   
14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

            PN

   

 

Page 3 of 17


CUSIP No. 45810N302

 

  1  

NAME OF REPORTING PERSON.

 

            BlueLine Capital Partners II, L.P.

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

SOURCE OF FUNDS (See Instructions)

 

            WC

   
  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ¨
  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  7    SOLE VOTING POWER

 

                0

 

  8    SHARED VOTING POWER

 

                53,544

 

  9    SOLE DISPOSITIVE POWER

 

                0

 

10    SHARED DISPOSITIVE POWER

 

                53,544

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            735,734

   
12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ¨
13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            8.5%

   
14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

            PN

   

 

Page 4 of 17


CUSIP No. 45810N302

 

  1  

NAME OF REPORTING PERSON.

 

            BlueLine Capital Partners III, L.P.

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

SOURCE OF FUNDS (See Instructions)

 

            WC

   
  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ¨
  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  7    SOLE VOTING POWER

 

                0

 

  8    SHARED VOTING POWER

 

                60,467

 

  9    SOLE DISPOSITIVE POWER

 

                0

 

10    SHARED DISPOSITIVE POWER

 

                60,467

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            735,734

   
12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ¨
13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            8.5%

   
14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

            PN

   

 

Page 5 of 17


CUSIP No. 45810N302

 

  1  

NAME OF REPORTING PERSON.

 

            BlueLine Catalyst Fund IX, L.P.

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

SOURCE OF FUNDS (See Instructions)

 

            WC

   
  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ¨
  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  7    SOLE VOTING POWER

 

                0

 

  8    SHARED VOTING POWER

 

                179,131

 

  9    SOLE DISPOSITIVE POWER

 

                0

 

10    SHARED DISPOSITIVE POWER

 

                179,131

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            735,734

   
12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ¨
13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            8.5%

   
14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

            PN

   

 

Page 6 of 17


CUSIP No. 45810N302

 

  1  

NAME OF REPORTING PERSON.

 

            BlueLine Partners, L.L.C.

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

SOURCE OF FUNDS (See Instructions)

 

            AF

   
  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ¨
  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  7    SOLE VOTING POWER

 

                0

 

  8    SHARED VOTING POWER

 

                325,963

 

  9    SOLE DISPOSITIVE POWER

 

                0

 

10    SHARED DISPOSITIVE POWER

 

                325,963

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            735,734

   
12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ¨
13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            8.5%

   
14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

            OO

   

 

Page 7 of 17


CUSIP No. 45810N302

 

  1  

NAME OF REPORTING PERSON.

 

            BlueLine Partners II, L.L.C.

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

SOURCE OF FUNDS (See Instructions)

 

            AF

   
  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ¨
  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  7    SOLE VOTING POWER

 

                0

 

  8    SHARED VOTING POWER

 

                60,467

 

  9    SOLE DISPOSITIVE POWER

 

                0

 

10    SHARED DISPOSITIVE POWER

 

                60,467

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            735,734

   
12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ¨
13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            8.5%

   
14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

             OO

   

 

Page 8 of 17


Item 1. Security and Issuer

This Schedule 13D relates to Common Stock (the “Common Stock”) of Integramed America, Inc. (the “Company”) with its principal executive offices located at Two Manhattanville Road, Purchase, New York 10577.

 

Item 2. Identity and Background

(a) This Schedule 13D filed by Blue TSV I, LTD, a Cayman Island exempt company (“TSV I”), BlueLine Capital Partners, LP, a Delaware limited partnership (“BCP I”), BlueLine Capital Partners II, LP, a Delaware limited partnership (“BCP II”), BlueLine Capital Partners III, LP, a Delaware limited partnership (“BCP III”), BlueLine Catalyst Fund IX, LP, a Delaware limited partnership (“Catalyst IX”), BlueLine Partners, L.L.C., a Delaware limited liability company (“BLGP I”), and BlueLine Partners II, L.L.C., a Delaware limited liability company (“BLGP II”, and together with the above named entities, the “Reporting Entities”). John Steven Kraus and Timothy P. Bacci are the directors of TSV I. Scott A. Shuda and Timothy P. Bacci are the managing directors of BLGP I and BLGP II. BCP I, BCP II, BCP III, BLGP I and BLGP II are collectively referred to herein as the “BlueLine Entities”.

(b) The business address of TSV I is c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, Cayman Islands KY1-1104. The business address of the other Reporting Entities and the individuals named in subsection (a) above is 402 Railroad Avenue, Suite 201, Danville, California 94526.

(c) TSV I is an investment corporation. Each of BCP I, BCP II, BCP III and Catalyst IX is an investment partnership. Each of BLGP I and BLGP II is an investment management firm that provides investment management services to private investment funds. BLGP I is the sole general partner of BCP I, BCP II, and Catalyst IX. BLGP II is the sole general partner of BCP III. This principal occupation of Mr. Kraus is to act as an advisor to various private investment firms. The principal occupation of Messrs. Shuda and Bacci is to act as managing directors of BLGP I and BLGP II. Subsection (b) above lists the mailing address of each of Messrs. Kraus, Shuda and Bacci.

(d) None of the Reporting Entities nor Messrs. Kraus, Shuda and Bacci has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) None of the Reporting Entities nor Messrs. Kraus, Shuda and Bacci has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws; and, if so, identify and describe such proceedings and summarize the terms of such judgment, decree or final order.

(f) TSV I is a Cayman Islands exempt company. Each of BCP I, BCP II, BCP III, and Catalyst IX is a Delaware limited partnership. Each of BLGP I and BLGP II is a Delaware limited liability company. Each of Messrs. Kraus, Shuda and Bacci are citizens of the United States.

 

Page 9 of 17


Item 3. Source and Amount of Funds

All of the funds used in making the purchase of the Shares described in Item 5 of this Schedule 13D came from the working capital of the Funds.

 

Item 4. Purpose of the Transaction

The Reporting Entities have purchased the Shares described in Item 5 of this Schedule 13D for investment purposes. Various of the BlueLine Entities have been investors in the Company since March 2006. Subsequent to that date, representatives of the BlueLine Entities have periodically discussed shareholder value issues with the Company’s management. The Reporting Entities expect such discussions will continue. While the Reporting Entities have no current plans that relate to or that would result in any of the transactions described in clauses (a) through (j) of Item 4 of Schedule 13D, the BlueLine Entities will continue to explore value creating opportunities, including those that could result in such transactions.

 

Item 5. Interest in Securities of the Issuer

(a) As of the date of this Schedule 13D, each of the Reporting Entities may be deemed to own 735,734 shares of Common Stock (the “Shares”). The Shares represent approximately 8.5% of the shares of Common Stock outstanding based on 8,645,694 shares of the Company’s Common Stock outstanding as reported in the Company’s Form 10-Q for the Company’s fiscal quarter ended September 30, 2008 as filed with the Securities and Exchange Commission on November 7, 2008.

The Reporting Entities are making this single, joint filing because they may be deemed to constitute a “group” within the meaning of Section 13(d)(3) of the Act. Each Reporting Entity expressly disclaims beneficial ownership of any of the shares of Common Stock other than those reported herein as being owned by it.

(b) As of the date of this Schedule 13D, TSV I has sole voting power and sole dispositive power with respect to 349,304 shares of the Common Stock of the Company and the BlueLine Entities have shared voting power and shared dispositive power with respect to 386,430 shares of the Common Stock of the Company.

(c) The following table details the transactions effected during the past sixty days or since the most recent filing of a Schedule 13D, whichever is less, by Reporting Entities (each of which was effected in an ordinary brokerage transaction).

 

TSV I      

Date

   No. of Shares    Price per Share

12/17/2008

   28,581    $ 6.00

12/18/2008

   20,300    $ 6.00

12/19/2008

   96,355    $ 6.01

12/22/2008

   194,068    $ 6.05

12/23/2008

   10,000    $ 6.36

 

Page 10 of 17


To the knowledge of the Reporting Entities, none of the executive officers or directors of TSV I, BLGP I, or BLGP II, has engaged in any transaction in any shares of the Issuer’s Common Stock during the sixty days immediately preceding the date hereof.

(d) No person (other than the Reporting Entities) is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares that are the subject of this Schedule 13D.

(e) Not applicable.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Pursuant to Rule 13d-1(k) promulgated under the Act, the Reporting Entities have entered into an agreement with respect to the joint filing of this statement, and any amendment or amendments hereto, which is attached hereto as Exhibit A.

 

Item 7. Materials to be Filed as Exhibits

 

  1. Exhibit A – Joint Filing Agreement dated December 31, 2008, signed by each of the Reporting Entities in order to confirm that this Schedule 13D is being filed on behalf of each of the Reporting Entities.

 

Page 11 of 17


SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: December 31, 2008

 

Blue TSV I, LTD
By:  

/s/ John Steven Kraus

Name:   John Steven Kraus
Title:   Director

 

Page 12 of 17


BlueLine Capital Partners, L.P.
By:   BlueLine Partners, L.L.C.
Its:   General Partner
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director
BlueLine Capital Partners II, L.P.
By:   BlueLine Partners, L.L.C.
Its:   General Partner
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director
BlueLine Capital Partners III, L.P.
By:   BlueLine Partners II, L.L.C.
Its:   General Partner
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director
BlueLine Catalyst Fund IX, L.P.
By:   BlueLine Partners, L.L.C.
Its:   General Partner
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director

 

Page 13 of 17


BlueLine Partners, L.L.C.
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director
BlueLine Partners II, L.L.C.
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director

 

Page 14 of 17


EXHIBIT A

Joint Filing Agreement

The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent it knows or has reason to believe that such information is inaccurate. This Joint Filing Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.

Date: December 31, 2008

 

Blue TSV I, LTD
By:  

/s/ John Steven Kraus

Name:   John Steven Kraus
Title:   Director

 

Page 15 of 17


BlueLine Capital Partners, L.P.
By:   BlueLine Partners, L.L.C.
Its:   General Partner
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director
BlueLine Capital Partners II, L.P.
By:   BlueLine Partners, L.L.C.
Its:   General Partner
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director
BlueLine Capital Partners III, L.P.
By:   BlueLine Partners II, L.L.C.
Its:   General Partner
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director
BlueLine Catalyst Fund IX, L.P.
By:   BlueLine Partners, L.L.C.
Its:   General Partner
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director

 

Page 16 of 17


BlueLine Partners, L.L.C.
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director
BlueLine Partners II, L.L.C.
By:  

/s/ Scott A. Shuda

Name:   Scott A. Shuda
Title:   Managing Director

 

Page 17 of 17